The logo of Teva Pharmaceutical Industries is seen during a The logo of Teva Pharmaceutical Industries is seen in Tel Aviv, Israel February 19, 2019. REUTERS/Amir Cohen/File photo Post navigation Previous: Huntington’s treatment helps Teva beat profit estimates as CEO eyes newer drug opportunities